Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
Christopher T. Letson(Saint Louis University), Eric Padron(Moffitt Cancer Center)
Cited by 5
Related Papers
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
|Nature Genetics|2020|739
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma
|Blood Cancer Discovery|2022|72
Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes
|Blood Cancer Discovery|2022|18